We are excited to introduce Jill Feldman, a dedicated lung cancer patient advocate, as our next oncoinfluencer.
Jill Feldman is active on X/Twitter and LinkedIn, where she shares her experiences and insights as a lung cancer patient and advocate. She is the Co-Founder of EGFR Resisters, an advocacy group for EGFR-positive lung cancer patients who are resistant to targeted treatment.
Follow Jill Feldman on X/Twitter and LinkedIn to stay informed about her impactful advocacy work and contributions to the lung cancer community.
About Jill Feldman
Jill serves as the Past President of the LUNGevity Foundation and is the Deputy Chair of IASLC’s Patient Advisory Board. She is also a member of The Chicago Institute of Translational Medicine’s Patient Advisory Board. Additionally, Jill is involved with the Department of Defense Lung Cancer Research Program as a member of the programmatic panel and serves on the planning committee for IASLC’s North America Conference on Lung Cancer. She is also a member of the ECOG-ACRIN Research Group’s Patient Advocate Committee and Thoracic Committee.
Stay tuned for more inspiring profiles in our oncoinfluencer series, and don’t miss our previous features highlighting influential voices in the oncology community.